tyrosine kinase inhibitor
midostaurin
venetoclax
thioguanine
ponatinib
olutasidenib
roscovitine
ivosidenib
idelalisib
antileukemic
chloraminophene
omacetaxine
ruxolitinib
antileukemia
asciminib
myeloleukemia
vosaroxin
carfilzomib
talacotuzumab
pacritinib
lenalidomide
pomalidomide
melphalan flufenamide
leukemic
homoharringtonine
tafasitamab
isatuximab
pegaspargase
clofarabine
506U78
promyeloleukemia
ubenimex
myeloleukemic
chemo
atiprimod
preleukemia
cytarabine
chemodrug
chronic leukemia
antileprotic
leukemogenicity
melphalan
picoplatin
Alkeran
belantamab mafodotin
trilaciclib
cytotoxic drug
acute lymphoblastic leukemia
chemicotherapeutic
tazemetostat